871 related articles for article (PubMed ID: 6277175)
21. Effects of atrio-ventricular conduction of calcium-antagonistic coronary vasodilators, local anaesthetics and quinidine injected into the posterior and the anterior septal artery of the atrio-ventricular node preparation of the dog.
Narimatsu A; Taira N
Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):169-77. PubMed ID: 1012337
[TBL] [Abstract][Full Text] [Related]
22. Calcium channel blocking drugs.
Johnston WE; Lowenstein E
Contemp Anesth Pract; 1983; 7():163-91. PubMed ID: 6309475
[No Abstract] [Full Text] [Related]
23. Comparative electrophysiologic and coronary hemodynamic effects of diltiazem, nisoldipine and verapamil on myocardial tissue.
Lathrop DA; Valle-Aguilera JR; Millard RW; Gaum WE; Hannon DW; Francis PD; Nakaya H; Schwartz A
Am J Cardiol; 1982 Feb; 49(3):613-20. PubMed ID: 7058769
[No Abstract] [Full Text] [Related]
24. In vitro and in vivo electrocardiographic evaluation of the novel calcium antagonist monatepil on cardiac conduction system.
Nose I; Kataoka T; Honda Y; Yamada T; Ikeno A; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T
Arzneimittelforschung; 1993 Jul; 43(7):722-8. PubMed ID: 8369002
[TBL] [Abstract][Full Text] [Related]
25. A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig.
Snowdy S; Liang HX; Blackburn B; Lum R; Nelson M; Wang L; Pfister J; Sharma BP; Wolff A; Belardinelli L
Br J Pharmacol; 1999 Jan; 126(1):137-46. PubMed ID: 10051130
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the cardiovascular effects of trans-diclofurime with different types of calcium antagonists in conscious spontaneously hypertensive rats.
Petty MA; Mir AK
Br J Pharmacol; 1988 Aug; 94(4):1218-24. PubMed ID: 3207982
[TBL] [Abstract][Full Text] [Related]
27. Differential antagonism by Bay k 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle.
Ishii K; Taira N; Yanagisawa T
Br J Pharmacol; 1985 Feb; 84(2):577-84. PubMed ID: 2579702
[TBL] [Abstract][Full Text] [Related]
28. Ro 40-5967, a novel calcium channel antagonist, protects against ventricular fibrillation.
Billman GE
Eur J Pharmacol; 1992 Dec; 229(2-3):179-87. PubMed ID: 1490522
[TBL] [Abstract][Full Text] [Related]
29. [Electrophysiologic effects of calcium channel blocking agents on the sinus node function in anesthetized dogs (author's transl)].
Nakaya H; Kanno M; Kanda K; Oyama Y
Nihon Yakurigaku Zasshi; 1980 Nov; 76(8):697-707. PubMed ID: 6268495
[TBL] [Abstract][Full Text] [Related]
30. Effects of nilvadipine on the cardiovascular system in experimental animals.
Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
[TBL] [Abstract][Full Text] [Related]
31. Calcium entry blockers: a review.
Goad DL
J Vet Pharmacol Ther; 1982 Dec; 5(4):233-9. PubMed ID: 6306265
[No Abstract] [Full Text] [Related]
32. Myocardial and vascular effects of efonidipine in vitro as compared with nifedipine, verapamil and diltiazem.
Tanaka H; Masumiya H; Sekine T; Sijuku T; Sugahara M; Taniguchi H; Terada M; Saito W; Shigenobu K
Gen Pharmacol; 1996 Apr; 27(3):451-4. PubMed ID: 8723524
[TBL] [Abstract][Full Text] [Related]
33. Differential potentiation by depolarization of the effects of calcium antagonists on contraction and Ca2+ current in guinea-pig heart.
Okuyama R; Adachi-Akahane S; Nagao T
Br J Pharmacol; 1994 Oct; 113(2):451-6. PubMed ID: 7834195
[TBL] [Abstract][Full Text] [Related]
34. [Calcium-antagonist-type cardiac effects of nifedipine in vitro and in vivo. Comparative experimental study].
Cosín J; Gimeno JV; Martín G; Ramírez A; Ferrer J; Báguena J
Rev Esp Cardiol; 1982; 35(5 Suppl 2):II115-22. PubMed ID: 7170402
[No Abstract] [Full Text] [Related]
35. Comparative cardiovascular effects of verapamil, nifedipine, and diltiazem during halothane anesthesia in swine.
Kates RA; Zaggy AP; Norfleet EA; Heath KR
Anesthesiology; 1984 Jul; 61(1):10-8. PubMed ID: 6742468
[TBL] [Abstract][Full Text] [Related]
36. Conscious state comparisons of the effects of the inhalation anesthetics and diltiazem, nifedipine, or verapamil on specialized atrioventricular conduction times in spontaneously beating dog hearts.
Atlee JL; Hamann SR; Brownlee SW; Kreigh C
Anesthesiology; 1988 Apr; 68(4):519-28. PubMed ID: 3354888
[TBL] [Abstract][Full Text] [Related]
37. Comparative effects of verapamil, nifedipine, and diltiazem on contractile function in the isolated immature and adult rabbit heart.
Boucek RJ; Shelton M; Artman M; Mushlin PS; Starnes VA; Olson RD
Pediatr Res; 1984 Oct; 18(10):948-52. PubMed ID: 6093034
[TBL] [Abstract][Full Text] [Related]
38. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.
Hamm CW; Opie LH
Circ Res; 1983 Feb; 52(2 Pt 2):I129-38. PubMed ID: 6831647
[No Abstract] [Full Text] [Related]
39. Differential effects of systemic and intracoronary calcium channel blocking agents on global and regional left ventricular function in conscious dogs.
Walsh RA; Badke FR; O'Rourke RA
Am Heart J; 1981 Sep; 102(3 Pt 1):341-50. PubMed ID: 6267919
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological basis for the therapeutic applications of slow-channel blocking drugs.
Singh BN
Angiology; 1982 Aug; 33(8):492-515. PubMed ID: 7051905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
